Top Markets
#1 Cortex Cortex +174.36%
#2 GEKKO GEKKO +51.79%
#3 ADO Protocol ADO Protocol +18.52%
#4 o1.exchange o1.exchange +10.89%
#5 Official Trump Official Trump +10.62%
#6 Audiera Audiera +10.49%
#7 Status Status +10.19%
#8 aelf aelf +9.22%
#9 DAPPOS DAPPOS +8.11%
#10 Seeker Seeker +6.62%
Coin of the day
Cortex Cortex
設定
言語
日本
通貨
USD
テーマ
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
株式のランク #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
株価
$59.98
最終同期: 2024-12-13
時価総額
$1.22B
変化（1日）
0.00%
変化（1年）
0.00%
国
US
取引 Longboard Pharmaceuticals, Inc. (LBPH)

カテゴリー

Healthcare
Longboard Pharmaceuticals, Inc.（LBPH）のP/B比率
August 2026 時点のP/B比率 TTM: 33.31
Longboard Pharmaceuticals, Inc. の最新の財務報告および株価によると、現在のP/B比率（TTM）は 33.31 です。2022 年末時点でのP/B比率は 0.91 でした。
Longboard Pharmaceuticals, Inc. の P/B 比率の履歴（2020 ～ 2026）
各年末時点のP/B比率
年 P/B比率 変化
2026 (TTM) 33.31 894.31%
2023 3.35 268.15%
2022 0.91 12.83%
2021 0.81 -85.45%
2020 5.54 0.00%
同業他社のP/B比率
企業 P/B比率 P/B比率の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -80.96%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -81.26%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -92.48%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -88.87%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH